Fujian Wanchen Biotechnology Co. Ltd (300972) — Financial Flexibility Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Financial Flexibility Index of 0.49x as of December 2025. Free cash flow of CN¥3.71 Billion (operating CF CN¥3.63 Billion minus capex CN¥77.44 Million) represents 0% of total liabilities (CN¥7.50 Billion). Check 300972 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fujian Wanchen Biotechnology Co. Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. See Fujian Wanchen Biotechnology Co. Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Fujian Wanchen Biotechnology Co. Ltd. For the full company profile including market capitalisation, see market cap of Fujian Wanchen Biotechnology Co. Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥3.71 Billion | CN¥3.63 Billion | CN¥7.50 Billion | ▲ +197.0% |
| 2024 | 0.17x | CN¥965.00 Million | CN¥848.35 Million | CN¥5.79 Billion | ▼ -56.7% |
| 2023 | 0.38x | CN¥1.24 Billion | CN¥1.02 Billion | CN¥3.23 Billion | ▼ -47.4% |
| 2022 | 0.73x | CN¥386.72 Million | CN¥70.38 Million | CN¥528.79 Million | ▲ +9.6% |
| 2021 | 0.67x | CN¥140.40 Million | CN¥98.82 Million | CN¥210.47 Million | ▼ -19.0% |
| 2020 | 0.82x | CN¥212.34 Million | CN¥156.24 Million | CN¥257.94 Million | ▲ +17.9% |
| 2019 | 0.70x | CN¥217.01 Million | CN¥177.28 Million | CN¥310.81 Million | — |